EdgarLookup

Balo Andrew K

Insider transactions at 2 companies

This page shows all SEC Form 4 filings attributed to Balo Andrew K. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

DXCM GCTK
Company Title Type Shares Price Value Date
GCTK Award / Grant 75 Oct 3, 2025
GCTK Award / Grant 4,490 Mar 26, 2025
DXCM EVP Regulatory Strategy Clinic Disposition 3,275 $111.40 $364,835 Mar 10, 2023
DXCM EVP, Global Medical Affairs Disposition 1,549 $406.06 $628,987 Mar 9, 2022
DXCM * Other 2,498 Sep 9, 2021
DXCM * Sale 300 $515.33 $154,599 Aug 3, 2021
DXCM * Sale 400 $429.33 $171,732 Jul 6, 2021
DXCM * Other 18,774 Jun 3, 2021
DXCM * Sale 5,566 $362.92 $2,020,013 Mar 10, 2021
DXCM * Award / Grant 5,301 Mar 8, 2021
DXCM * Sale 5,256 $397.35 $2,088,472 Sep 15, 2020
DXCM * Sale 1,283 $398.30 $511,019 Sep 9, 2020
DXCM * Sale 200 $361.45 $72,290 Jun 15, 2020
DXCM * Sale 51 $287.75 $14,675 Apr 15, 2020
DXCM * Sale 319 $250.15 $79,798 Mar 11, 2020
DXCM * Award / Grant 8,811 Mar 8, 2020
DXCM * Sale 2,386 $151.46 $361,384 Sep 18, 2019
DXCM * Sale 269 $158.42 $42,615 Sep 9, 2019
DXCM * Sale 37 $170.00 $6,290 Sep 3, 2019
DXCM * Sale 7,825 $125.00 $978,125 Jun 5, 2019
DXCM * Sale 2,222 $142.79 $317,279 Mar 12, 2019
DXCM * Award / Grant 14,987 Mar 8, 2019
DXCM EVP, Reg. Strategy, Clinical Sale 627 $120.23 $75,384 Dec 14, 2018
DXCM EVP, Reg. Strategy, Clinical Sale 1,200 $141.25 $169,500 Nov 14, 2018
DXCM EVP, Reg. Strategy, Clinical Sale 2,991 $124.49 $372,350 Oct 12, 2018
DXCM EVP, Reg. Strategy, Clinical Sale 4,400 $145.27 $639,188 Sep 14, 2018
DXCM EVP, Reg. Strategy, Clinical Sale 3,180 $143.76 $457,157 Sep 10, 2018
DXCM EVP, Reg. Strategy, Clinical Sale 550 $124.96 $68,728 Aug 14, 2018
DXCM EVP, Reg. Strategy, Clinical Sale 500 $100.73 $50,365 Jul 16, 2018
DXCM EVP, Reg. Strategy, Clinical Disposition 2,221 $60.73 $134,881 Mar 12, 2018
DXCM EVP, Reg. Strategy, Clinical Award / Grant 38,502 Mar 8, 2018
DXCM EVP, Reg. Strategy, Clinical Sale 3,245 $61.23 $198,691 Dec 11, 2017
DXCM EVP, Reg. Strategy, Clinical Sale 6,490 $60.00 $389,400 Nov 29, 2017
DXCM EVP, Reg. Strategy, Clinical Disposition 4,184 $71.81 $300,453 Sep 11, 2017
DXCM EVP, Reg. Strategy, Clinical Sale 3,244 $71.18 $230,908 Aug 10, 2017
DXCM EVP, Reg. Strategy, Clinical Sale 3,200 $71.55 $228,960 Jul 10, 2017
DXCM EVP, Clinical and Regulatory Sale 3,200 $69.06 $220,992 Jun 12, 2017
DXCM EVP, Clinical and Regulatory Sale 3,200 $71.93 $230,176 May 10, 2017
DXCM EVP, Clinical and Regulatory Sale 3,200 $78.19 $250,208 Apr 10, 2017
DXCM EVP, Clinical and Regulatory Disposition 6,694 $77.55 $519,120 Mar 10, 2017
DXCM EVP, Clinical and Regulatory Award / Grant 28,761 Mar 8, 2017
DXCM EVP, Clinical and Regulatory Sale 727 $79.30 $57,651 Feb 10, 2017
DXCM EVP, Clinical and Regulatory Sale 3,200 $62.86 $201,152 Jan 10, 2017
DXCM EVP, Clinical and Regulatory Sale 4,997 $82.31 $411,303 Oct 19, 2016
DXCM EVP, Clinical and Regulatory Sale 5,000 $82.55 $412,750 Oct 5, 2016
DXCM EVP, Clinical and Regulatory Sale 5,000 $92.87 $464,350 Sep 21, 2016
DXCM EVP, Clinical and Regulatory Disposition 4,445 $93.72 $416,585 Sep 9, 2016
DXCM EVP, Clinical and Regulatory Sale 4,999 $94.45 $472,156 Sep 7, 2016
DXCM EVP, Clinical and Regulatory Option Exercise 5,000 $3.19 $15,950 Aug 24, 2016
DXCM EVP, Clinical and Regulatory Option Exercise 5,000 $3.19 $15,950 Aug 10, 2016